Net Profit Margin ratio Analysis of Glaxosmithkline Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY NPM
Period Ending - Mar-25
Very Good NPM
24.74
Period Ending - Mar-24
Good NPM
17.20
Growth
43.82 %
Trailing Twelve Months NPM
Period Ending - Mar-25
Very Good NPM
25.41
Most recent Quarter NPM
Period Ending - Jun-25
Very Good NPM
25.46
NPM Analysis of Glaxosmithkline Pharmaceuticals Ltd.
| NPM Ratio of Glaxosmithkline Pharmaceuticals Ltd. with value of 25.41 indicates that a company is able to control its costs effectively and offer goods or services at a much higher price than its costs in trailing twelve months. |
| NPM Ratio of Glaxosmithkline Pharmaceuticals Ltd. with value of 25.46 indicates that a company is able to control its costs effectively and offer goods or services at a much higher price than its costs in latest Quarter ending on Jun-25. |
| NPM Ratio of GLAXO rose handsomely by 43.82 % this year. |
| NPM Ratio with value of 51.70 was highest in Year Mar-22 in last Five Years. |
| NPM Ratio with value of 12.24 was lowest in Year Mar-21 in last Five Years. |
| Latest NPM Ratio with value of 24.74 is lower than Average NPM of 24.97 in last five years. |
Other NPM Related Info of GLAXO that may interest you.
Glaxosmithkline Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| GLAXO | 2618.60 | 2621.70 | 0.118 % | Drugs & Pharma |
Defination of Net Profit Margin
Net Margin is the company's Net Profit divided by the Total Revenue. This profitability metric indicates how much a net profit is generated for each rupee of revenue earned. In simple terms, it tells how much the company is generating profit for each rupee of revenue earned in percentage. It measures the company's profitability and management's capability to manage its expenses to generate profit. more ..
NPM Related Ratios
| ReturnOnEquity | EBITDAMargin |
Tsr Profitability Index
| Mild Profitability | Screener |
FY - Historical Net Profit Margin of Glaxosmithkline Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| NPM | 24.74 | 17.20 | 18.97 | 51.70 | 12.24 | 2.89 | 14.24 |
| Change | 43.82 % | -9.30 % | -63.31 % | 322.31 % | 323.53 % | -79.70 % | 16.57 % |
| Price | 2880.35 | 1946.60 | 1324.75 | 1666.90 | 1440.75 | 1257.40 | 1297.45 |
| Price Change | 47.97 % | 46.94 % | -20.53 % | 15.70 % | 14.58 % | -3.09 % | 24.29 % |